Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of the benefits to the NHS in England of early endovenous ablation of leg ulcers.

The results of the Early Venous Reflux Ablation (EVRA) study (2018) and the Effect of Surgery and Compression on Healing and Recurrence (ESCHAR) trial (2004) indicate that early superficial endovenous ablation improves healing of venous leg ulceration, reduces the risk of ulcer recurrence and is cost-effective.

Therefore, the results of the EVRA study and the ESCHAR trial will be incorporated into the National Wound Care Strategy Programme recommendations for care, as this will bring benefits to both patients and the National Health Service.